(Q41677917)

7 October 2017

1 reference

title

Surveillance for Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis: Effective and Justified? (English)

1 reference

primary sclerosing cholangitis

7 October 2017

ascending cholangitis

0 references

cholangiocarcinoma

0 references

sclerosing cholangitis

1 reference

based on heuristic

inferred from title

1 reference

2

Gregory J Gores

1 reference

7 October 2017

Nataliya Razumilava

1

1 reference

7 October 2017

29 August 2016

1 reference

7 October 2017

Clinical liver disease

1 reference

7 October 2017

8

1 reference

7 October 2017

2

1 reference

7 October 2017

43-47

1 reference

Duration of Inflammatory Bowel Disease Is Associated With Increased Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis and IBD.

7 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5096651

Screening for Cancer: Considerations for Low- and Middle-Income Countries

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5096651

Malignancies in Primary Sclerosing Cholangitis--A Continuing Threat

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5096651

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5096651

Current consensus on the management of primary sclerosing cholangitis

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5096651

Cancer surveillance in patients with primary sclerosing cholangitis

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5096651

Natural history of small duct primary sclerosing cholangitis: a case series with review of the literature

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5096651

ACG Clinical Guideline: Primary Sclerosing Cholangitis.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5096651

Primary sclerosing cholangitis with equivocal cytology: fluorescence in situ hybridization and serum CA 19-9 predict risk of malignancy.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5096651

Diagnosis and management of primary sclerosing cholangitis.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5096651

EASL Clinical Practice Guidelines: management of cholestatic liver diseases.

18 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCLD.567

Trends in pre-liver transplant screening for cholangiocarcinoma among patients with primary sclerosing cholangitis

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5096651

High lifetime risk of cancer in primary sclerosing cholangitis

3 November 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCLD.567

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CLD.567

1 reference

release_omjyhgt3bfhwzcx4sjsfm5ipxm

7 October 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/omjyhgt3bfhwzcx4sjsfm5ipxm

mapped directly with Wikidata item

24 November 2022

based on heuristic

PMC publication ID

5096651

1 reference

PMC publication ID

5096651

7 October 2017

PubMed publication ID

27822365

1 reference

PMC publication ID

5096651